Category: Clinical

SJiMB21: A molecular path to treating infants with medulloblastoma

Posted by Kathryn McCullough and Jessie Newman | May 18, 2023

At St. Jude, clinical trial SJiMB21 seeks to provide treatment strategies for infants and young children diagnosed with medulloblastoma that place the patient, not just the tumor, at the center of care.

Learn more

Research adds to understanding of AYA patients

Posted by Kerry Hillis Goff | Apr 6, 2023

Psychological, social and behavioral research sheds light on the needs of adolescents and young adults with cancer.

Learn more

Diagnostic Imaging receives hospital’s first Expanded Access use designation from FDA

Posted by Matt Gaschk | Dec 29, 2022

St. Jude received the hospital’s first expanded access designation from the FDA for use of PET scans with [11C]Methionine a tracer that makes imaging results clearer.

Learn more

St. Jude advice to young adults with sickle cell disease: Stay connected

Posted by Mary Powers | Nov 28, 2022

The St. Jude Methodist Sickle Cell Disease Transition Clinic helps patients move from pediatric to adult care, an important stage where patients often experience roadblocks to maintaining their health.

Learn more

Studies of rare craniopharyngioma reveal ways to improve long-term outcomes for patients

Posted by Erin Podolak | Nov 15, 2022

A St. Jude clinical trial launched more than 25 years ago has helped to transform understanding and care for children with the brain tumor craniopharyngioma.

Learn more

Latin American hospitals implement tool to identify kids whose condition is deteriorating

Posted by Mary Powers | Nov 1, 2022

Flexible and tailored implementation strategies helped pediatric cancer centers across Latin America scale up a proven quality improvement strategy.

Learn more

SAFER Ukraine: a framework for responding to global conflicts

Posted by Erin Podolak | May 26, 2022

What lessons can be learned from the remarkable success of SAFER Ukraine?

Learn more

Five years later: gene therapy for ‘bubble boy’ disease

Posted by Alex Generous, PhD | May 19, 2022

Interim results point to enduring immune function following gene therapy for Infants with ‘bubble boy’ disease

Learn more

Reflecting on nearly 40 years of progress against pediatric brain tumors

Posted by Erin Podolak | May 16, 2022

May is Brain Tumor Awareness Month and a good time to learn more about the diverse group of diseases that make up the most common childhood solid tumor.

Learn more

The double-edged sword of being both parent and blood stem cell donor

Posted by Alex Generous, PhD | Mar 8, 2022

What are the potential psychological and emotional risks and rewards for parents who serve as their children’s bone marrow donors?

Learn more